PharmaOPS.BXL
ActiveSummary
The computed 12-month bankruptcy probability of PharmaOPS.BXL is 15.0% (high). The 2024 annual accounts show equity of €6,268 and a net result of €5,268. Its solvency ranks better than 10% of 9,537 sector peers (NACE 47, financial year 2024). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- PharmaOPS.BXL
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région bruxelloise, par simple décision de l’organe d’administration” (deed in French)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- Two directors jointly
- Board ruleHow the board is made up, meets and takes decisions.
- “Assemblée générale, un ou plusieurs administrateurs,personnes physiques ou morales,actionnaires ou non” (deed in French)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- 30 May at 09:00